Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat Titration for Gout Flare Prophylaxis
NCT04697602Terminated
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of febuxostat in gout (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Incidence rate of gout flare at 12 weeks. Started Jan 2021; status: terminated.
02
Drugs
febuxostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT04697602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04697602.